Have you ever wondered what the new antibacterial strategies are?

As part of my work with the Institute for Molecular Bioscience at UQ, we have just published an open access review in ACS Infectious Diseases of antibacterial candidates in clinical trials published , as well as selected compounds still in the early stages of development, that have modes of action (MoAs) not found in marketed antibacterial drugs (antibiotics). Our hope is that this review will encourage further research into new treatment options for drug-resistant infections.